As of Nov 25
| +0.88 / +11.97%|
The 1 analysts offering 12-month price forecasts for InVivo Therapeutics Holdings Corp have a median target of 25.00, with a high estimate of 25.00 and a low estimate of 25.00. The median estimate represents a +203.77% increase from the last price of 8.23.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.